
|Articles|September 1, 2002
Neither party animal nor party pooper
Even before botulinum toxin (Botox Cosmetic) received FDA approval in April for use in cosmetic procedures, the demand for the treatment had made Botox the fifth most common nonsurgical cosmetic procedure in the country.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
4
Oral STAT6 Degrader KT-621 Shows Biologic-Comparable Activity in Atopic Dermatitis
5














